Aandeel A042520 HANSBIOMED CORPORATION
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen HansBiomed Corporation

Aandelen

A042520

KR7042520007

slotkoers Korea S.E.
Andere beurzen
 00:00:00 16-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
13.960 KRW +3,48% Intraday-grafiek van HansBiomed Corporation +7,47% -4,90%
14/02 HansBiomed Corporation rapporteert resultaten voor het eerste kwartaal eindigend op 31 december 2023 CI
2023 HansBiomed Corporation meldt winstcijfers voor het tweede kwartaal en de zes maanden eindigend op 31 maart 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023
HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index
HansBiomed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
HansBiomed Corporation's Equity Buyback announced on June 23, 2022, has expired with 202,283 shares, representing 2.08% for KRW 1,986.65 million.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
HansBiomed Corporation(KOSDAQ:A042520) dropped from S&P Global BMI Index
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
HansBiomed Corporation's Equity Buyback announced on January 17, 2022, has expired with 246,000 shares, representing 2.46% for KRW 2,962.2 million.
HansBiomed Corporation announces an Equity Buyback for KRW 2,000 million worth of its shares.
HansBiomed Corporation authorizes a Buyback Plan.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
HansBiomed Corporation announces an Equity Buyback for KRW 3,000 million worth of its shares.
HansBiomed Corporation authorizes a Buyback Plan.
HansBiomed Corporation Auditor Raises 'Going Concern' Doubt
HansBiomed Corporation announced that it has received KRW 15 billion in funding from Noh & Partners Corporation
Rebirth Biotechnology Co., Ltd announced that it has received CNY 20 million in funding from HansBiomed Corporation
Rebirth Biotechnology Co., Ltd announced that it expects to receive CNY 20 million in funding from HansBiomed Corporation
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers A042520
  4. Nieuws HansBiomed Corporation
  5. Andere talen